Department of Clinical and Translational Sciences, Joan C. Edwards School of Medicine, Marshall University, Huntington, WV 25701, USA.
Department of Internal Medicine, Joan C. Edwards School of Medicine, Marshall University, Huntington, WV 25701, USA.
Int J Mol Sci. 2024 Oct 18;25(20):11208. doi: 10.3390/ijms252011208.
Malabsorption of NaCl is the primary cause of diarrhea in inflammatory bowel disease (IBD). Coupled NaCl absorption occurs via the dual operation of Na:H and Cl:HCO exchange in the brush border membrane (BBM) of villus cells. Cl:HCO exchange is mediated by BBM transporters DRA (downregulated in adenoma) and PAT1 (putative anion transporter 1) in the mammalian small intestine. DRA/PAT1-mediated Cl:HCO exchange was significantly downregulated in the BBM of villus cells in a rabbit model of chronic ileitis, while Na:H exchange was unaffected. The inhibition of Cl:HCO exchange was restored in the rabbits when treated with a broad-spectrum immunomodulator, i.e. a glucocorticoid, indicating that the downregulation of DRA/PAT1 is likely to be immune-mediated during chronic enteritis. Mucosal mast cells are one type of key immune cells that are known to proliferate and release immune inflammatory mediators, thus playing a significant role in the pathogenesis of IBD. However, how mast cells may regulate DRA- and PAT1-mediated Cl:HCO exchange in a rabbit model of chronic ileitis is unknown. In this study, treatment of rabbits with chronic intestinal inflammation with the mast cell stabilizer ketotifen did not affect the mucosal architecture of the inflamed intestine. However, ketotifen treatment reversed the inhibition of Cl:HCO activity in the BBM of villus cells. This restoration of Cl:HCO activity to normal levels by ketotifen was found to be secondary to restoring the affinity of the exchangers for its substrate chloride. This observation was consistent with molecular studies, where the mRNA and BBM protein expressions of DRA and PAT1 remained unaffected in the villus cells under all experimental conditions. Thus, this study indicates that mast cells mediated the inhibition of coupled NaCl absorption by inhibiting Cl:HCO exchange in a rabbit model of chronic enteritis.
NaCl 的吸收不良是炎症性肠病(IBD)腹泻的主要原因。耦合 NaCl 吸收是通过绒毛细胞刷状缘膜(BBM)中 Na:H 和 Cl:HCO 交换的双重作用实现的。Cl:HCO 交换由哺乳动物小肠中的 BBM 转运体 DRA(腺瘤下调)和 PAT1(假定阴离子转运体 1)介导。在慢性回肠炎兔模型中,绒毛细胞 BBM 中的 DRA/PAT1 介导的 Cl:HCO 交换显著下调,而 Na:H 交换不受影响。当用广谱免疫调节剂(即糖皮质激素)治疗兔子时,Cl:HCO 交换的抑制作用得到恢复,表明在慢性肠炎期间 DRA/PAT1 的下调可能是免疫介导的。黏膜肥大细胞是一种已知增殖并释放免疫炎症介质的关键免疫细胞,因此在 IBD 的发病机制中发挥重要作用。然而,肥大细胞如何调节慢性回肠炎兔模型中 DRA 和 PAT1 介导的 Cl:HCO 交换尚不清楚。在这项研究中,用肥大细胞稳定剂酮替芬治疗患有慢性肠道炎症的兔子不会影响发炎肠道的黏膜结构。然而,酮替芬治疗逆转了绒毛细胞 BBM 中 Cl:HCO 活性的抑制。酮替芬将 Cl:HCO 活性恢复到正常水平是通过恢复交换对其底物氯的亲和力来实现的。这一观察结果与分子研究一致,在所有实验条件下,绒毛细胞中的 DRA 和 PAT1 的 mRNA 和 BBM 蛋白表达均不受影响。因此,这项研究表明,肥大细胞通过抑制慢性肠炎兔模型中的 Cl:HCO 交换来介导耦合 NaCl 吸收的抑制。